These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39350048)

  • 1. Health-related quality of life measured with K-BILD is associated with survival in patients with idiopathic pulmonary fibrosis.
    Rautajoki T; Rantala HA; Sutinen E; Saarto T; Rajala K; Pesonen I; Hollmen M; Myllärniemi M; Lehto JT
    BMC Pulm Med; 2024 Sep; 24(1):480. PubMed ID: 39350048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Bendstrup E
    Respir Res; 2020 Apr; 21(1):91. PubMed ID: 32316976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.
    Rautajoki T; Lehto JT; Sutinen E; Bergman P; Sintonen H; Rajala K; Mäkelä K; Hollmen M; Saarto T; Myllärniemi M
    J Palliat Med; 2023 Oct; 26(10):1357-1364. PubMed ID: 37366772
    [No Abstract]   [Full Text] [Related]  

  • 5. Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.
    Wapenaar M; Patel AS; Birring SS; Domburg RTV; Bakker EW; Vindigni V; Sköld CM; Cottin V; Vancheri C; Wijsenbeek MS
    Chron Respir Dis; 2017 May; 14(2):140-150. PubMed ID: 28019103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life.
    Rajala K; Lehto JT; Sutinen E; Kautiainen H; Myllärniemi M; Saarto T
    BMC Pulm Med; 2018 Nov; 18(1):172. PubMed ID: 30458739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.
    Kotecha J; Atkins C; Wilson A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):341-348. PubMed ID: 28079846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases.
    Birring SS; Bushnell DM; Baldwin M; Mueller H; Male N; Rohr KB; Inoue Y
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.
    Moor CC; Mostard RLM; Grutters JC; Bresser P; Aerts JGJV; Chavannes NH; Wijsenbeek MS
    Am J Respir Crit Care Med; 2020 Aug; 202(3):393-401. PubMed ID: 32325005
    [No Abstract]   [Full Text] [Related]  

  • 10. A role for cardiopulmonary exercise testing in detecting physiological changes underlying health status in Idiopathic pulmonary fibrosis: a feasibility study.
    Davis R; Dixon C; Millar AB; Maskell NA; Barratt SL
    BMC Pulm Med; 2021 May; 21(1):147. PubMed ID: 33952224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in a multiracial Asian interstitial lung disease cohort.
    Phua G; Tan GP; Phua HP; Lim WY; Neo HY; Chai GT
    J Thorac Dis; 2022 Dec; 14(12):4713-4724. PubMed ID: 36647495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease.
    Patel AS; Siegert RJ; Keir GJ; Bajwah S; Barker RD; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Respir Med; 2013 Sep; 107(9):1438-43. PubMed ID: 23867809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.
    Durheim MT; Hoffmann-Vold AM; Eagan TM; Hovden AO; Lund MB; Bjerke G; Birring SS; Jonassen TM; Johansen OE; Sjåheim T
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32576559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.
    Oğuz MS; Bingöl Z; Pıhtılı A; Karaca Özer P; Sarıtaş Arslan M; Kılıçaslan Z; Bilge AK; Kıyan E; Okumuş G
    BMC Pulm Med; 2024 Jul; 24(1):373. PubMed ID: 39085811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.
    Scallan C; Strand L; Hayes J; Kadura S; Collins B; Ho L; Spada C; Canestaro W; Kolb M; Raghu G
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34112729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis.
    Kim JW; Clark A; Birring SS; Atkins C; Whyte M; Wilson AM
    Chron Respir Dis; 2021; 18():14799731211033925. PubMed ID: 34609156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the IPF-specific version of St. George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E
    Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.
    Szentes BL; Kreuter M; Bahmer T; Birring SS; Claussen M; Waelscher J; Leidl R; Schwarzkopf L
    Respir Res; 2018 May; 19(1):101. PubMed ID: 29801506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.
    Patel AS; Siegert RJ; Brignall K; Gordon P; Steer S; Desai SR; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Thorax; 2012 Sep; 67(9):804-10. PubMed ID: 22555278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.